ID: ALA5286796

Max Phase: Preclinical

Molecular Formula: C21H22ClNO

Molecular Weight: 339.87

Associated Items:

Representations

Canonical SMILES:  O=C1c2ccc(-c3ccccc3)cc2C(NC2CCCCC2)C1Cl

Standard InChI:  InChI=1S/C21H22ClNO/c22-19-20(23-16-9-5-2-6-10-16)18-13-15(11-12-17(18)21(19)24)14-7-3-1-4-8-14/h1,3-4,7-8,11-13,16,19-20,23H,2,5-6,9-10H2

Standard InChI Key:  YJUMITZTMJDTNJ-UHFFFAOYSA-N

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 339.87Molecular Weight (Monoisotopic): 339.1390AlogP: 5.12#Rotatable Bonds: 3
Polar Surface Area: 29.10Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: 1HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 8.01CX LogP: 5.17CX LogD: 4.47
Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.79Np Likeness Score: 0.18

References

1. Perry GS, Das M, Woon ECY..  (2021)  Inhibition of AlkB Nucleic Acid Demethylases: Promising New Epigenetic Targets.,  64  (23.0): [PMID:34792334] [10.1021/acs.jmedchem.1c01694]

Source